(Q40418987)

20 September 2017

1 reference

title

Advances in the management of patients with thyroid disease (English)

1 reference

20 September 2017

Dworkin HJ

1

1 reference

20 September 2017

Meier DA

series ordinal

2

1 reference

20 September 2017

Kaplan M

series ordinal

3

1 reference

20 September 2017

publication date

1 July 1995

1 reference

Seminars in Nuclear Medicine

20 September 2017

published in

1 reference

20 September 2017

volume

25

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

205-220

1 reference

Generation of recombinant, enzymatically active human thyroid peroxidase and its recognition by antibodies in the sera of patients with Hashimoto's thyroiditis

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Disappearance of Thyrotropin-Blocking Antibodies and Spontaneous Recovery from Hypothyroidism in Autoimmune Thyroiditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Pathogenesis of Graves' ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Pathogenesis of Graves' ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Smoking and Risk of Graves' Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Cigarette smoking and the thyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Medullary thyroid carcinoma, genes, and the prevention of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Applications of a new chemiluminometric thyrotropin assay to subnormal measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Hyperthyroidism, thyroid hormone therapy, and bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Levothyroxine therapy in patients with thyroid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Thyroid hormone therapy. What, when, and how much

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Monitoring thyroxine treatment during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Gross and microscopic findings in clinically normal thyroid glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Thyroid gland: US screening in a random adult population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Management of a solitary thyroid nodule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Fine-needle aspiration biopsy of the thyroid: an appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Thyroid and parathyroid imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Positron emission tomography of thyroid masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

High-Resolution Real-Time Ultrasonography of Thyroid Nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Percutaneous ethanol injection treatment of autonomously functioning single thyroid nodules: optimization of treatment and short term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Large, compressive goiters treated with radioiodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Natural history, treatment, and course of papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Radionuclide therapy of the thyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Tall cell carcinoma of the thyroid gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Differentiated thyroid carcinomas: the relevance of various pathological features for tumour classification and prediction of tumour progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Papillary and follicular thyroid carcinomas with an insular component

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

"Insular" carcinoma of thyroid. A subset of anaplastic thyroid malignancy with a less aggressive clinical course.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Survival discriminants for differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Cancer risks in thyroid cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

A preliminary report of thyroglobulin release after fine needle aspiration biopsy of thyroid nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Thyroid cancer diagnosis and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Measurement of serum thyroglobulin is of value in detecting tumour recurrence following treatment of differentiated thyroid carcinoma by lobectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Histology and immunocytochemistry of differentiated thyroid carcinomas do not predict radioiodine uptake: a clinicomorphological study of 62 recurrent or metastatic tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Long-Term Results of Treatment of 283 Patients with Lung and Bone Metastases from Differentiated Thyroid Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

Solitary thyroid nodule: diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980011-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-2998(95)80011-5

1 reference

20 September 2017

1 reference